Clonidine and Epilepsy aggravated - a phase IV clinical study of FDA data

Summary:

Epilepsy aggravated is reported as a side effect among people who take Clonidine (clonidine), especially for people who are male, 30-39 old, have been taking the drug for 6 - 12 months also take Pantoprazole, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Epilepsy aggravated when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Epilepsy aggravated?

Epilepsy aggravated (serious common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,073 drugs and 456 conditions by eHealthMe. Check the latest studies of Epilepsy aggravated.

On Jul, 17, 2026

63,883 people reported to have side effects when taking Clonidine.
Among them, 49 people (0.08%) have Epilepsy aggravated.

Could Clonidine cause Epilepsy aggravated?

Among these 49 people:

How long have people been on Clonidine when they have Epilepsy aggravated? *

What is the gender of people who have Epilepsy aggravated when taking Clonidine? *

female: 41.86 %
male: 58.14 %

What is the age of people who have Epilepsy aggravated when taking Clonidine? *

What are other drugs people take besides Clonidine? *

What are other side effects people have besides Epilepsy aggravated? *

Weakness: 10 people, 20.41%
Nausea And Vomiting: 10 people, 20.41%
Dizziness: 9 people, 18.37%
Nausea (feeling of having an urge to vomit): 6 people, 12.24%
Drowsiness: 6 people, 12.24%
Blood Pressure Systolic Increased: 6 people, 12.24%
Blood Pressure Systolic Abnormal: 6 people, 12.24%
Blood Pressure Fluctuation: 6 people, 12.24%
Heart Rate Decreased: 6 people, 12.24%
Confusional State: 5 people, 10.20%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 14.29%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 6.12%
Antithrombin Iii Deficiency (rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism, and repetitive intrauterine fetal death (iufd)): 2 people, 4.08%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 4.08%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.08%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 4.08%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 1 person, 2.04%
Breast Cancer: 1 person, 2.04%
Depression: 1 person, 2.04%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 1 person, 2.04%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Epilepsy aggravated?

- Check whether Epilepsy aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clonidine:

Clonidine (65,644 reports)

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy aggravated:

Epilepsy aggravated (1,073 drugs)

Browse all the conditions that are associated with Epilepsy aggravated:

Epilepsy aggravated (456 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.